JACC-Heart Failure

Scope & Guideline

Advancing the Understanding of Heart Failure

Introduction

Welcome to your portal for understanding JACC-Heart Failure, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN2213-1779
PublisherELSEVIER SCI LTD
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 2013 to 2024
AbbreviationJACC-HEART FAIL / JACC-Heart Fail.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address125 London Wall, London EC2Y 5AS, ENGLAND

Aims and Scopes

The journal 'JACC: Heart Failure' focuses on the advancement of knowledge in the field of heart failure through rigorous research and clinical insights. It emphasizes the importance of guideline-directed medical therapy, innovative treatment strategies, and the management of comorbid conditions associated with heart failure.
  1. Heart Failure Management Strategies:
    The journal covers clinical trials and studies focusing on the management of heart failure, including pharmacological interventions, device therapy, and rehabilitation approaches.
  2. Epidemiology and Risk Factors:
    Research on the epidemiology of heart failure, including the identification of risk factors, comorbidities, and social determinants of health that influence patient outcomes.
  3. Innovative Therapies and Technologies:
    Exploration of new therapeutic strategies, including the use of sodium-glucose cotransporter inhibitors, novel devices, and digital health technologies for heart failure management.
  4. Patient-Centered Care:
    Emphasis on the importance of patient-reported outcomes, quality of life assessments, and the integration of patient preferences in heart failure treatment plans.
  5. Guideline-Directed Medical Therapy (GDMT):
    Studies focusing on the implementation, adherence, and optimization of GDMT in diverse populations, including challenges faced in clinical practice.
  6. Health Disparities in Heart Failure:
    Investigation into disparities in heart failure care and outcomes based on race, ethnicity, gender, and socioeconomic status.
Recent publications in 'JACC: Heart Failure' reveal several emerging themes that reflect the evolving landscape of heart failure research, focusing on innovative approaches, personalized medicine, and comprehensive care models.
  1. Digital Health and Telemedicine:
    A significant increase in studies exploring the use of digital health technologies, telemedicine, and remote patient monitoring for managing heart failure, especially post-COVID-19.
  2. SGLT2 Inhibitors and Heart Failure:
    Growing research interest in the application of SGLT2 inhibitors for heart failure management, highlighting their benefits beyond diabetes control and their impact on heart failure outcomes.
  3. Comorbid Conditions and Integrated Care:
    Emerging focus on the management of comorbidities alongside heart failure, particularly in relation to chronic kidney disease, obesity, and mental health, emphasizing a holistic approach to patient care.
  4. Health Equity and Social Determinants of Health:
    Increasing attention on health disparities and social determinants affecting heart failure outcomes, driving research that seeks to address inequities in access to care and treatment.
  5. Personalized Medicine Approaches:
    A trend towards personalized treatment strategies in heart failure, incorporating genetic, phenotypic, and biomarker data to tailor therapies to individual patient needs.

Declining or Waning

While 'JACC: Heart Failure' continues to thrive in many areas of research, certain themes are becoming less prominent in recent publications. These waning scopes reflect shifts in clinical focus and emerging evidence that may influence future research directions.
  1. Traditional Heart Failure Biomarkers:
    Research on conventional biomarkers like BNP and NT-proBNP is seeing a decline as newer, more comprehensive diagnostic approaches and biomarkers gain traction in heart failure management.
  2. Invasive Procedures for Diagnosis and Management:
    There is a noticeable decrease in studies centered on invasive procedures, such as routine cardiac biopsies or catheterizations, as non-invasive and remote monitoring technologies are increasingly preferred.
  3. Single-Factor Studies:
    Research focusing solely on single interventions or factors in heart failure is declining in favor of multi-faceted approaches that consider the complexity of patient care and the interaction of various treatment modalities.

Similar Journals

Heart International

Exploring innovative insights in cardiology and cardiovascular medicine.
Publisher: TOUCH MEDICAL MEDIA LTDISSN: 2036-2579Frequency: 2 issues/year

Heart International is a prominent open-access journal dedicated to the fields of cardiology and cardiovascular medicine, published by TOUCH MEDICAL MEDIA LTD since 2006. Based in Italy, this journal serves as a vital platform for researchers, clinicians, and students, aiming to disseminate cutting-edge scientific findings and clinical insights that advance the understanding of heart health. With an ISSN of 2036-2579 and an emphasis on accessible content, Heart International ensures that valuable research is available to a wide audience, thereby contributing to the global discourse on cardiovascular issues. Although it currently holds a Q4 quartile ranking in its category and is positioned in the lower percentile for Scopus rankings, the journal is committed to improving its impact through rigorous peer review and high-quality publications. The journal covers a wide array of topics within the cardiology domain, making it an essential resource for those looking to stay abreast of the latest developments in heart research.

Current Heart Failure Reports

Navigating the Complexities of Heart Failure
Publisher: SPRINGERNATUREISSN: 1546-9530Frequency: 6 issues/year

Current Heart Failure Reports, published by SpringerNature, is a leading journal dedicated to advancing the field of cardiology, specifically focusing on heart failure. With an impressive impact factor and a recognized reputation, this journal falls under the top quartiles in several categories, including Q1 in Cardiology and Cardiovascular Medicine and Emergency Medicine. Its range of topics encompasses both clinical and research insights into heart failure management, offering valuable perspectives aligned with the latest therapeutic advancements. Although it does not have open access options, researchers and practitioners can find profound studies and reviews aimed at improving patient care and outcomes in cardiovascular health. As the journal converges towards its 20th year in print, it continues to serve as a critical resource for academic professionals, providing a platform for high-quality research that shapes the future of heart failure treatments.

Egyptian Heart Journal

Exploring the frontiers of cardiology for global impact.
Publisher: SPRINGERISSN: 1110-2608Frequency: 1 issue/year

The Egyptian Heart Journal, published by Springer, is a premier open-access journal dedicated to advancing the field of cardiology and cardiovascular medicine. As of 2023, it holds a Q3 classification within the category, showcasing its growing influence within the research community, and ranks 241 out of 387 in Scopus, reflecting a 37th percentile position. With an E-ISSN of 2090-911X, this journal has been open access since 2011, making it easily accessible to researchers, practitioners, and students alike. The journal aims to disseminate high-quality research articles, reviews, and case studies that contribute to the understanding and treatment of cardiovascular diseases. With its focus on innovative and practical solutions in cardiology, the Egyptian Heart Journal plays a critical role in shaping current and future cardiovascular research. Its global outreach and commitment to open access ensure that vital information is available to a wide audience, enhancing both scholarly discourse and clinical practice in the evolving landscape of cardiovascular medicine.

Indian Heart Journal

Championing Open Access to Cardiovascular Insights
Publisher: ELSEVIERISSN: 0019-4832Frequency: 6 issues/year

Indian Heart Journal, published by Elsevier, is a distinguished peer-reviewed journal dedicated to the field of cardiology and cardiovascular medicine. Founded in 1961, this journal has been a pivotal resource for researchers, healthcare professionals, and students, providing a platform for innovative studies and insights into heart health. The journal transitioned to an Open Access model in 2013, ensuring widespread dissemination of vital research findings to enhance global understanding of cardiovascular diseases. Ranked in the Q3 category for Cardiology and Cardiovascular Medicine in 2023, it holds a reputable position in the medical community, with a Scopus rank of #222 out of 387 journals in the same field, placing it in the 42nd percentile. The Indian Heart Journal strives to foster advances in clinical practice and research while addressing the unique cardiac health challenges faced in India and beyond.

World Journal of Cardiology

Exploring the frontiers of cardiology and cardiovascular medicine.
Publisher: BAISHIDENG PUBLISHING GROUP INCISSN: 1949-8462Frequency: 12 issues/year

World Journal of Cardiology, published by BAISHIDENG PUBLISHING GROUP INC, stands out as a pivotal resource in the field of cardiology and cardiovascular medicine. With an ISSN of 1949-8462, this journal serves a global audience, promoting knowledge dissemination and collaboration among researchers, healthcare professionals, and students dedicated to advancing cardiovascular health. The journal demonstrates its credibility and impact in the field by achieving a respectable Q2 ranking in the 2023 category of Cardiology and Cardiovascular Medicine. Notably, it is listed in the Scopus database, ranking #189 out of 387 journals, placing it in the 51st percentile, which underscores its relevance and contribution to contemporary cardiovascular research. Although it operates under a subscription model, the journal provides diverse access options, ensuring that critical findings reach a wide audience. Through its comprehensive scope and commitment to publishing high-quality articles, the World Journal of Cardiology plays a vital role in shaping the future of cardiovascular science, making it an invaluable asset for those involved in this essential discipline.

Journal of the Saudi Heart Association

Exploring Innovations in Cardiology and Patient Care
Publisher: DIGITAL COMMONS BEPRESSISSN: 1016-7315Frequency: 4 issues/year

The Journal of the Saudi Heart Association is a prominent scholarly publication dedicated to advancing knowledge in the fields of cardiology and cardiovascular medicine. Published by DIGITAL COMMONS BEPRESS, this open-access journal has been serving the global community since 2009, providing a vital platform for researchers, practitioners, and students interested in the latest developments in heart health and disease management. With an ISSN of 1016-7315 and a growing repository of knowledge alongside an E-ISSN of 2212-5043, the journal showcases an array of peer-reviewed articles that contribute to the understanding of cardiovascular conditions. Although categorized in the Q4 quartile for 2023, it remains committed to offering valuable insights, particularly within the constraints of the 29th percentile rank specified by Scopus. As the journal converges towards 2024, it continues to foster collaboration, innovation, and inquiry within the Saudi Arabian and international medical communities.

International Journal of Cardiology

Leading the Charge in Heart Health Innovations
Publisher: ELSEVIER IRELAND LTDISSN: 0167-5273Frequency: 24 issues/year

The International Journal of Cardiology is a premier publication in the field of Cardiology and Cardiovascular Medicine, published by Elsevier Ireland Ltd. With an impressive impact factor and ranked in the top quartile (Q1) of its category, this journal serves as a vital resource for researchers, clinicians, and scholars committed to advancing cardiovascular health. Founded in 1981, the journal has been pivotal in disseminating significant findings, with a wide-ranging scope that includes original research, reviews, and clinical studies aimed at improving patient outcomes and understanding heart diseases. Its robust ranking of #73 out of 387 in Scopus ensures that it remains a leading platform for impactful cardiovascular research. While currently not an open-access publication, the journal's commitment to quality and relevance makes it an essential reference point within an ever-evolving medical landscape. For those engaged in cardiovascular research, the International Journal of Cardiology is not just a journal; it's an indispensable source of knowledge shaping the future of heart health.

REVISTA ESPANOLA DE CARDIOLOGIA

Advancing Cardiovascular Knowledge with Every Issue
Publisher: EDICIONES DOYMA S AISSN: Frequency: 12 issues/year

REVISTA ESPANOLA DE CARDIOLOGIA is a premier journal dedicated to the dynamic field of cardiology, published by EDICIONES DOYMA S A in Barcelona, Spain. With an impressive Q1 status in the Medicine (miscellaneous) category for 2023, this journal is recognized for its significant contributions to cardiovascular research, evidenced by its rank of #61 out of 387 in the Scopus database, placing it within the top 16% of journals in its field. Covering a broad range of topics within cardiology, the journal aims to disseminate high-quality research, clinical studies, and educational content, fostering knowledge sharing among researchers, clinicians, and students alike. While it does not currently offer open access, the journal maintains a commitment to advancing cardiovascular health through rigorous peer-reviewed articles. With a publication history that spans from 2013 to 2024, REVISTA ESPANOLA DE CARDIOLOGIA is an essential resource for those seeking to stay at the forefront of cardiology advancements and practices.

Korean Circulation Journal

Exploring the Frontiers of Cardiac Research and Innovation.
Publisher: KOREAN SOC CARDIOLOGYISSN: 1738-5520Frequency: 12 issues/year

Korean Circulation Journal, published by the Korean Society of Cardiology, has established itself as a prominent platform for disseminating research in the fields of Cardiology and Cardiovascular Medicine. With an ISSN of 1738-5520 and an E-ISSN of 1738-5555, this journal has been at the forefront of cardiovascular science since its inception in 2006 and is projected to continue until 2024. The journal's commitment to quality is reflected in its 2023 category quartiles, ranking in the second quartile (Q2) for both Cardiology and Internal Medicine, as well as its commendable Scopus rankings within the respective fields. Located in South Korea, the journal aims to bridge the gap between cutting-edge research and practical applications, serving as an invaluable resource for researchers, healthcare professionals, and students keen on advancing their understanding of cardiovascular health. Although currently not an open-access journal, it provides a wealth of knowledge that encourages evidence-based practice in clinical settings.

CIRCULATION

Elevating Cardiology: Where Innovation Meets Excellence.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 0009-7322Frequency: 50 issues/year

CIRCULATION is a premier journal in the field of cardiology and cardiovascular medicine, published by Lippincott Williams & Wilkins. With a distinguished history dating back to 1950, the journal has consistently been at the forefront of critical research, showcasing significant advancements and discoveries in cardiovascular health. It holds a remarkable Q1 ranking in both the fields of Cardiology and Physiology (medical) according to the 2023 category quartiles, demonstrating its influential role among the top publications in these disciplines. With an impressive Scopus ranking, placed 3rd out of 387 in Cardiology and 2nd out of 113 in Physiology, CIRCULATION is essential reading for researchers, practitioners, and students passionate about advancing their understanding of heart health and related medical sciences. Although the journal is not open access, it continues to foster scholarly exchange and innovation in cardiovascular research, making it an indispensable resource for quality insights and groundbreaking studies.